4//SEC Filing
Flynn Daniel Lee 4
Accession 0001209191-20-046330
CIK 0001654151other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 4:00 PM ET
Size
7.9 KB
Accession
0001209191-20-046330
Insider Transaction Report
Form 4
Flynn Daniel Lee
Chief Scientific Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-08-10−9,029→ 0 totalExercise: $1.89Exp: 2025-12-17→ Common Stock (9,029 underlying) - Exercise/Conversion
Common Stock
2020-08-10$1.89/sh+9,029$17,065→ 237,475 total
Holdings
- 91,020(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option vests in 48 equal monthly installments at the end of each month following the vesting commencement date of September 30, 2015, subject to continued service through such dates.
Documents
Issuer
Deciphera Pharmaceuticals, Inc.
CIK 0001654151
Entity typeother
Related Parties
1- filerCIK 0001713712
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 4:00 PM ET
- Size
- 7.9 KB